Pearl vs Diagnocat: Dental AI Compared (2026)

Overview

Both Pearl and Diagnocat read dental radiographs with AI and surface pathology a busy clinician might overlook — but they were built around different centers of gravity. In the Pearl vs Diagnocat decision, the real question isn't "which AI is smarter?" It's "what kind of imaging does your practice live in?" Pearl grew up chairside, layering instant, color-coded detections onto everyday 2D x-rays to standardize diagnosis and move case acceptance conversations forward. Diagnocat grew up in the CBCT volume, turning dense 3D scans into structured radiology reports and navigable visualizations that specialists and imaging centers rely on.

If you want the short version of each platform first, our independent Pearl review and Diagnocat review cover pricing, ratings, and feature depth in detail. This guide is the head-to-head: where each one pulls ahead, where they overlap, and which practice profile each was built to serve.

Our take: Pearl is the broader, more general-practice-friendly choice — it holds FDA clearance across both 2D and 3D imaging, plugs into a wide range of PMS and sensor systems, and is purpose-built to lift case acceptance through patient-facing visuals. Diagnocat is the deeper 3D specialist — when your day revolves around CBCT, implant planning, endodontic assessment, or multi-specialty work, its structured CBCT reporting and 3D model generation are hard to match. Neither is the "better" platform in the abstract. The right answer is the one whose strengths line up with the imaging you actually do most.

At a Glance

Feature Comparison

2D Radiograph AI

This is the modality most general practices live in day to day, and it's where Pearl has built its reputation. Second Opinion analyzes bitewings, periapicals, and panoramics in roughly 30 seconds, flagging up to 18 findings per image — caries at early and progressed stages, calculus, bone loss, periapical radiolucency, defective margins, and existing restorations — with color-coded overlays designed to be read at a glance during the exam. Independent validation puts disease-detection accuracy in the 94-95% range, and the detections appear chairside in real time.

Diagnocat is also a genuine 2D platform, not a 3D-only tool. Globally it reads 40+ conditions across panoramic, periapical, and full-mouth-series images and returns an annotated report, typically in under a minute. The difference is emphasis: Pearl optimizes 2D for instant, in-operatory review and patient conversation, while Diagnocat treats 2D as one input into a broader, report-first diagnostic workflow. For practices whose core need is fast, standardized reads on everyday x-rays, Pearl's chairside-first design is the more natural fit.

3D / CBCT AI

CBCT is Diagnocat's home turf, and it shows. The platform reads 60+ conditions on CBCT scans, performs automated segmentation of DICOM volumes, and — distinctively — generates 3D STL models directly from the scan that export into surgical-planning software. That turns raw cone-beam data into navigable visualizations and structured reports without a separate segmentation step, which is exactly what implant, endo, and oral-surgery workflows need. Reports on a full CBCT volume generally land in the four-to-six-minute range.

Pearl entered 3D more recently with Second Opinion 3D, which identifies critical anatomical structures in CBCT scans — dentition, the inferior alveolar canal, maxillary sinus, nasal space, airway, and more — with high segmentation accuracy across regions. It's a meaningful and growing capability, and it makes Pearl the rare platform that spans both modalities under one roof. But for practices doing heavy 3D every day, Diagnocat's deeper, more mature CBCT reporting and model-generation pipeline is its signature advantage.

FDA Clearance & Regulatory

Both platforms are FDA-cleared, which already separates them from much of the dental AI field — but the shape of each clearance is worth understanding. Pearl is the first and only dental AI company cleared by the FDA for both 2D and 3D radiologic analysis (Second Opinion for 2D, Second Opinion 3D for CBCT), giving it the broadest cleared footprint across modalities in the US market. Pearl is also cleared in a long list of international markets, including CE, Canada, Australia, and New Zealand.

Diagnocat secured FDA clearance for the US market in 2025, with its cleared CBCT tool focused on computer-assisted detection of periapical radiolucency on cone-beam images — a clinically meaningful, second-read indication that opened the door to American practices. Internationally, Diagnocat's capabilities run broader than its current US clearance. The practical read: if breadth of US-cleared coverage across both 2D and 3D matters to your compliance posture, Pearl leads today; if your priority is FDA-cleared CBCT support specifically, Diagnocat now delivers that.

Integrations, PMS & Imaging Fit

Pearl is built to slot into existing general-practice infrastructure. It integrates with 30+ imaging and practice-management platforms — Dentrix, Eaglesoft, Open Dental, Curve, CareStack, Oryx, and many sensor systems — so detections appear inside the software the team already uses. That tight fit is a big part of why Pearl scales cleanly across DSOs standardizing clinical quality. One thing worth noting: because Pearl flows through integrated capture software, externally referred radiographs don't always upload directly, so confirm your specific sensor and PMS combination during the demo.

Diagnocat takes a hardware-agnostic, cloud-first approach. It works with images from essentially any device that outputs standard DICOM or image files, and it lists smooth compatibility with CBCT systems from Sirona, Vatech, Planmeca, and Carestream. For an imaging center or multi-specialty group pulling scans from varied equipment, that flexibility is a real asset. The trade-off is that Diagnocat's North American PMS-integration ecosystem is still maturing relative to Pearl's, so general practices that want detections embedded directly in their day-to-day PMS should validate that workflow up front.

Case Acceptance & Patient Communication

Pearl treats patient communication as a first-class feature, not a byproduct. The same annotated, color-coded images the dentist reviews become the visual the patient sees — turning abstract greyscale shadows into clearly marked areas a non-clinical audience can understand. Practices consistently cite this as one of Pearl's most impactful effects, and Pearl reports meaningful lifts in treatment acceptance when AI supports the conversation. If raising case acceptance is a primary goal, this is squarely in Pearl's wheelhouse. Our guide to the best AI dental imaging software digs further into how visual AI shapes the treatment conversation.

Diagnocat supports case acceptance too, particularly through its detailed, objective reports — patients tend to trust findings from a neutral AI that has nothing to gain from the diagnosis. Its strength here leans toward complex, 3D-driven cases, where a structured report and 3D visualization help a patient grasp an implant or endodontic situation that a flat x-ray can't convey. Both platforms move acceptance forward; Pearl's is tuned for everyday 2D conversations, Diagnocat's for the high-stakes 3D ones.

Reporting & Analytics

Beyond detections, Pearl layers on Practice Intelligence — an analytics dashboard tracking clinical quality scores, case acceptance rates, production by provider, and appointment utilization in real time. That gives owners and DSO leadership an operational view that extends well past the operatory, which is part of why Pearl resonates with groups managing quality across many locations.

Diagnocat's reporting strength runs in a different direction: clinical depth per case. Its automated radiology reports translate a complex scan into a structured, shareable diagnostic document — valuable for referrals, specialist collaboration, and documentation. So the analytics question splits cleanly: Pearl for practice-wide operational and business metrics, Diagnocat for rich, case-level diagnostic reporting.

Pricing Comparison

Both platforms are quote-based, so the comparison here is relative rather than line-item — and you'll get an accurate number only through each vendor's sales conversation. Pearl prices by location and notably offers a 30-day trial, which lowers the barrier to seeing real detections on your own radiographs before committing; that trial is a genuine advantage for a practice that wants to evaluate fit risk-free. For a closer look at how Pearl structures its tiers, see our Pearl pricing breakdown.

Diagnocat also uses quote-based, per-location pricing and routes buyers through a sales conversation rather than a public price page. Relative to Pearl, expect the value equation to track usage: practices running high CBCT volume tend to find Diagnocat's 3D reporting justifies its investment, while general practices weighing mostly-2D needs often find Pearl's broader integration footprint and trial period easier to pilot first. Neither is positioned as the budget option; both are premium-investment, modular platforms where the right tier depends on volume and modality mix. Because pricing moves over time, treat the demo quote — not any third-party figure — as the source of truth.

What Users Say

Clinicians who use Pearl most often praise the real-time, chairside experience and the patient-communication lift — the annotated overlays make findings obvious to patients and standardize how a multi-doctor practice reads x-rays. Pearl carries a 9.0 TMR rating and a 4.3 on Capterra. Worth noting in the feedback: some users mention occasional false positives on interproximal caries and want a direct import path for externally referred images — fair points to probe during a trial, and exactly what the 30-day window is for.

Diagnocat earns its strongest reviews from CBCT-heavy and specialist users. Endodontists and implant-focused clinicians repeatedly highlight the FDA-cleared 3D diagnostics, the structured CBCT reports, and the automated model generation as workflow-changing. Independent reviewers have long noted that Diagnocat was one of the first platforms to handle 3D CBCT analysis seriously, and that reputation holds. The recurring theme: practices doing complex 3D work value the diagnostic depth, while its North American integration ecosystem is still expanding — an established-but-growing presence in the US market.

Who Should Choose Pearl

Pearl is the stronger fit if your practice profile looks like this:

• General and multi-location practices whose volume is mostly 2D bitewings, periapicals, and panoramics, and who want instant chairside detections.
• Owners focused on case acceptance who want patient-facing visual annotations baked into the exam.
• DSOs standardizing clinical quality across locations, who benefit from Practice Intelligence analytics and tight PMS integration.
• Practices that want the broadest US FDA-cleared coverage spanning both 2D and 3D imaging under one vendor.
• Buyers who want to try before they commit — the 30-day trial makes evaluating fit low-risk.

If that's you, the diagnostic breadth, integration depth, and acceptance tooling make Pearl the more natural default.

Who Should Choose Diagnocat

Diagnocat is the stronger fit if your practice profile looks like this:

• CBCT-heavy practices and imaging centers where 3D volume is the daily reality, not the occasional scan.
• Implant, endodontic, and oral-surgery workflows that need structured CBCT reports and STL models that export into surgical planning.
• Multi-specialty group practices that pull scans from varied equipment and value a hardware-agnostic, DICOM-friendly platform.
• Clinicians who want FDA-cleared CBCT support specifically and deep, case-level diagnostic reporting for referrals and documentation.

If your work lives in the CBCT volume, Diagnocat's 3D depth is its decisive advantage.

The Bottom Line

Pearl vs Diagnocat isn't a contest with a loser — it's a fork in the road based on the imaging your practice actually does. Pearl wins on breadth: the widest US FDA-cleared coverage across 2D and 3D, deep PMS integration, real-time chairside detections, and best-in-class tooling for case acceptance — the right default for general practices and DSOs standardizing quality. Diagnocat wins on depth: the most mature CBCT reporting and 3D model generation in the category, purpose-built for implant, endo, and multi-specialty work where cone-beam volume drives the day.

Pick the platform whose strengths match your modality mix, confirm integration fit during the demo, and — if you can — use Pearl's 30-day trial to pressure-test detections on your own radiographs before you decide.

Still weighing which dental AI fits your practice? Take our 2-minute software match quiz and we'll point you toward the platforms built for how you actually work.